To determine whether PDIA3 regulates myoblast differentiation and fusion via AKT/mTOR signaling, we first showed that the inhibition of PDIA3 significantly reduced p-AKT and eMyHC expression in CTX-damaged muscle (Fig. 7a). Here, MTOR is linked to cerebrotendinous xanthomatosis.